About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(KRT14-Vegfa)3Dtm
transgene insertion 3, Michael Detmar
MGI:3655101
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
tg1
Tg(KRT14-Vegfa)3Dtm/0 FVB/N-Tg(KRT14-Vegfa)3Dtm MGI:3655625


Genotype
MGI:3655625
tg1
Allelic
Composition
Tg(KRT14-Vegfa)3Dtm/0
Genetic
Background
FVB/N-Tg(KRT14-Vegfa)3Dtm
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(KRT14-Vegfa)3Dtm mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• pronounced in dermis after oxazolone challenge
• despite increased angiogenesis and vasculogenesis, wound closure is slightly delayed in transgenic mice compared to wild-type

immune system
• mice display enhanced density of adherent leukocytes (251.9/mm2 vs 61.3/mm2 in wild-type)
• postcapillary venules show an increased proportion of rolling leukocytes compared to venules in wild-type skin (47.9% vs 15.6%, respectively)
• there is increased mast cell localization to sites of angiogenesis compared to controls (35% increase in mast cell density compared to wild-type)
• number of macrophages in granulation tissue is increased 2-fold compared to wild-type at day 7 after wounding but at days 10 and 14, numbers are equivalent to wild-type
• 24 hours after oxazolone challenge, lymph nodes draining the challenges side of transgenics are enlarged
• transgenic mice rapidly form a lymphatic vasculature at the site of the wound whereas no lymphatic vessels are found at day 7 post-wounding and only a few sprouting vessels are seen at day 10 in wild-type mice
• mutants show enlarged dermal lymphatics in non-inflamed skin compared to wild-type
• lymphatic vessels are significantly larger in mutants (935 um2 compared to wild-type, 592 um2) 30 days after DTH induction
• after induction of delayed-type hypersensitivity (DTH) reactions, skin of wild-type mice show tissue edema and a transient enlargement of lymphatic vessels which declines after 7 days and returns to baseline in 1 month; mutants show prolonged ear-swelling, and enhanced and persistent lymphatic vessel enlargement still detectable 1 month after initiation

hematopoietic system
• mice display enhanced density of adherent leukocytes (251.9/mm2 vs 61.3/mm2 in wild-type)
• postcapillary venules show an increased proportion of rolling leukocytes compared to venules in wild-type skin (47.9% vs 15.6%, respectively)
• there is increased mast cell localization to sites of angiogenesis compared to controls (35% increase in mast cell density compared to wild-type)
• number of macrophages in granulation tissue is increased 2-fold compared to wild-type at day 7 after wounding but at days 10 and 14, numbers are equivalent to wild-type

cardiovascular system
• in 3-week old transgenics, capillaries in the skin show a highly increased tortuosity index (+69%) compared to wild-type with a corresponding average decreased length without branching
• at 3 weeks of age
• mutants have significantly higher numbers of blood vessels in normal skin compared to wild-type (J:92643)
• 3-week old transgenic mice show increased angiogenesis in the skin (J:104245)
• transgenic mice display an increased density of blood microvessels in the dermis of the abdomen, dorsal region and ear at 3 days of age compared to controls; increase is less dramatic at 11 days, 3 weeks and 6 weeks (J:104245)
• vascularization of granulation tissue remains elevated for three weeks following wounding, compared to control mice (J:111924)
• extravasation of dye in non-inflamed ears of transgenic mice is significantly higher (34 ng/mg) than wild-type (7 ng/mg) (J:92643)
• 24 hours after oxazolone challenge, baseline leakage increased 10 fold in wild-type and 11.5-fold in transgenic animals compared to vehicle-treated mice; 7 days after treatment leakage is diminished in wild-type and mutant mice but is still much higher in mutants (J:92643)
• induced new dermal capillaries in the ear skin are hyperpermeable (J:104245)

integument
• pronounced in dermis after oxazolone challenge
• dense inflammatory infiltrates of CD4+ lymphocytes within the dermis, as well as CD8+ lymphocytes within the epidermis
• epidermis contains fingerlike, anatomosing extensions protruding into the dermis after oxazolone challenge
• epidermis of the ears is parakeratotic 1 month after oxazolone challenge
• 1 month after oxazolone challenge, ears display epidermal hyperplasia
• 1 month after oxazolone challenge, ears of mice show a psoriasis-like phenotype

cellular
• mice display enhanced density of adherent leukocytes (251.9/mm2 vs 61.3/mm2 in wild-type)
• postcapillary venules show an increased proportion of rolling leukocytes compared to venules in wild-type skin (47.9% vs 15.6%, respectively)

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
psoriasis DOID:8893 OMIM:PS177900
J:92643





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory